JP2024533426A5 - - Google Patents
Info
- Publication number
- JP2024533426A5 JP2024533426A5 JP2024515577A JP2024515577A JP2024533426A5 JP 2024533426 A5 JP2024533426 A5 JP 2024533426A5 JP 2024515577 A JP2024515577 A JP 2024515577A JP 2024515577 A JP2024515577 A JP 2024515577A JP 2024533426 A5 JP2024533426 A5 JP 2024533426A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- ch2oc
- inhibitor
- substituted
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163243539P | 2021-09-13 | 2021-09-13 | |
| US63/243,539 | 2021-09-13 | ||
| PCT/US2022/076360 WO2023039600A1 (en) | 2021-09-13 | 2022-09-13 | Drug conjugates of sugar derivatives and uses thereof as senolytic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533426A JP2024533426A (ja) | 2024-09-12 |
| JP2024533426A5 true JP2024533426A5 (cg-RX-API-DMAC10.html) | 2025-09-22 |
Family
ID=85507744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515577A Pending JP2024533426A (ja) | 2021-09-13 | 2022-09-13 | 糖誘導体の薬物コンジュゲート及び老化細胞除去剤としてのその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20230137021A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4380575A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024533426A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118475356A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022342245A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3232213A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023039600A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11897915B2 (en) * | 2021-09-13 | 2024-02-13 | Rubedo Life Sciences, Inc. | Sugar derivatives and uses thereof to prepare novel senolytic agents |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2890981T3 (en) * | 2012-08-28 | 2019-03-04 | Univ Tuebingen Medizinische Fakultaet | Senescence tracers |
| US9993472B2 (en) * | 2014-01-28 | 2018-06-12 | Unity Biotechnology, Inc. | Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 |
| JP7419347B2 (ja) * | 2018-04-23 | 2024-01-22 | エイジェックス・セラピューティクス・インコーポレイテッド | 哺乳動物細胞における組織再生の誘導及びセノリシスのための改良された方法 |
| MX2021000395A (es) * | 2018-07-11 | 2021-05-12 | Rubedo Life Sciences Inc | Composiciones senolíticas y usos de las mismas. |
-
2022
- 2022-09-13 CN CN202280072208.7A patent/CN118475356A/zh active Pending
- 2022-09-13 WO PCT/US2022/076360 patent/WO2023039600A1/en not_active Ceased
- 2022-09-13 CA CA3232213A patent/CA3232213A1/en active Pending
- 2022-09-13 US US17/943,824 patent/US20230137021A1/en not_active Abandoned
- 2022-09-13 JP JP2024515577A patent/JP2024533426A/ja active Pending
- 2022-09-13 AU AU2022342245A patent/AU2022342245A1/en active Pending
- 2022-09-13 EP EP22868391.8A patent/EP4380575A4/en active Pending
-
2024
- 2024-05-06 US US18/655,834 patent/US20240299555A1/en not_active Abandoned
-
2025
- 2025-02-10 US US19/049,614 patent/US20250222115A1/en active Pending